Background: NSAIDs are used as first-line drugs for the treatment of various
inflammatory disorders. Chronic use of NSAIDs is known to be associated with gastrointestinal and
renal toxicity. Local generation of reactive oxygen species finally resulting in cellular apoptosis is
one of the accepted mechanisms for NSAID-induced toxicity.
Objective: The objective of the present study was to design and synthesize a series of 2-methane
sulfonamido substituted arylthiazole derivatives by including structural features of combined
antiulcer and anti-inflammatory activity utilizing as the structural core, thiazole nucleus with
potential for antioxidant effect.
Methods: Compounds were designed based on three dimensional and field similarity studies. The
synthesized compounds were evaluated for their anti-inflammatory activity in carrageenan-induced
rat paw edema model. Rofecoxib and indomethacin were taken as standard drugs for comparison.
The in vitro antioxidant activity was assessed in potassium ferricyanide reducing power (PFRAP)
assay employing ascorbic acid as the standard drug.
Results: The compounds 6 and 7 showed good anti-inflammatory activity comparable to the
standard group and were also non ulcerogenic at the test doses. Compounds 1-7 displayed varying
degrees of reducing power in the PFRAP) assay and the methanesulphonamido derivatives 4-7
showed the highest antioxidant activity (EC50 values 3.7-5.1 μmol/ml vs ascorbic acid 7.4 μmol/ml).
Theoretical ADME profiling of the compounds based on selected physicochemical properties
showed excellent compliance with Lipinski’s rule.
Conclusion: A series of compounds have been designed and synthesized having dual antioxidant
and anti-inflammatory activity with activities comparable to standard drugs.